Clinical Trial 49932

Winter Park, FL 32789


A phase 2/3, interventional safety, pharmacokinetics, and efficacy, open-label, multi-center, single-arm study to investigate orally administered pf-07321332 (nirmatrelvir)/ritonavir in nonhospitalized symptomatic pediatric participants with covid-19 who are at risk of progression to severe disease.

Qualified Participants Must:

• Ages birth to less than or equal to 18 years old
• confirmed SARS-CoV2 infection
• has at least 1 underlying medical characteristic associated with an increased risk of developing COVID-19 including Overweight or Obese, Immunosuppressive disease, Chronic Lung Disease, known Hypertension, Cardiovascular Disease, Type 1 or Type 2 Diabetes Mellitus, Chronic Kidney Disease, Sickle Cell Disease, Neurodevelopmental disorder

Qualified Participants May Receive:

Compensation may be available for qualified study participants

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.